After having her first child, Dr. Amanda Kahn, an internist and longevity specialist based in New York City, turned to a GLP-1 medication to shed the persistent baby weight. Later, she sought help from plastic surgeon Darren Smith to address loose skin on her arms through a minimally invasive procedure called BodyTite, which employs radiofrequency technology to tighten skin both internally and externally. Dr. Kahn’s journey mirrors a growing trend among individuals using weight loss medications, who are noticing changes in their skin and face. Projections suggest that by 2030, around 30 million people in the U.S. might be utilizing these medications, prompting an influx of non-invasive cosmetic treatments and skincare products aimed at countering the effects of rapid weight loss.
Experts have indicated that rapid weight loss, especially from GLP-1 drugs, can lead to significant changes in the skin, resulting in increased sagging and wrinkling. Plastic surgeon Julius Few explains that the action of these drugs directly affects the epidermis and dermis, causing alterations that go beyond mere skin laxity. Patients often find their skin loses hydration, collagen, and elastin, leading to a rubber band-like texture. Furthermore, users may experience issues such as rosacea and changes in pigmentation. Though some people undergoing treatment find themselves undernourished due to reduced appetite, experts highlight that careful management, such as losing weight gradually and maintaining high protein intake, can alleviate some of these side effects.
The phenomenon popularly termed “Ozempic face,” though now often referred to as “GLP-1 face” or “GLP-1 skin,” has sparked the beauty industry to innovate. New skincare products designed specifically for GLP-1 users are emerging; brands like Dr. Few Skincare and Image Skincare are launching clinically tested solutions. Dr. Few created a product named DermaReverse after witnessing the unique skin changes in his patients. This skincare product combines bioavailable retinoic acid, peptides, and botanical antioxidants to stimulate the body’s natural production of collagen and elastin, addressing issues like skin laxity and pigmentation effectively.
Image Skincare has also entered the market with its Vol.u.lift GLP-1 4D Skin Rebound Complex. This product incorporates a blend of ingredients aimed at countering the symptoms associated with the GLP-1 experience, such as dehydration and deep wrinkles. Dr. Marc Ronert of Image Skincare believes there’s a significant opportunity for expansion in this area, including developing products specifically tailored for bodily transformations resulting from weight loss. However, there is a concern about how consumers will perceive the terminology associated with these products, and experts emphasize the need for careful marketing to avoid alienating potential buyers.
As new products flood the market, many users are turning to both non-invasive and slightly more invasive treatments to combat their skin issues. Procedures such as Emsculpt Neo and Morpheus8 are gaining popularity among those seeking a more pronounced transformation, while others might opt for traditional surgical options like tummy tucks and facelifts. Medical professionals acknowledge that this newly emerging demographic includes individuals who may never have considered cosmetic surgery before. Many practitioners are adapting their treatment protocols to cater specifically to post-GLP-1 patients, focusing on multi-faceted approaches to restore skin and body contours.
Interestingly, not all effects of GLP-1 medications on the skin are negative. Initial studies looked at the potential use of these drugs for treating chronic inflammatory skin conditions such as psoriasis, and some reports suggest users may experience improvements in conditions like rosacea. As the healthcare industry learns more about the impacts of these medications, practitioners are developing holistic strategies for skin health, including facials, increased protein intake, and red light therapy. This comprehensive understanding of GLP-1’s effects is resonating with many users, leading to increased spending not only on beauty products but also on fashion and accessories, reflecting a newfound confidence as they engage more actively with their physical selves.
As the landscape of beauty and health continues to evolve, fueled by advances in medications like GLP-1, the potential for new consumer behaviors and market trends seems vast. With projections indicating that a considerable percentage of Americans may be on GLP-1 by 2025, many in the industry believe we are just beginning to scratch the surface of this evolving narrative surrounding weight loss and its cosmetic ramifications.